GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-1,283 Cr | ₹2.09 Cr | ₹4,561 Cr | ₹-528 Cr | ₹-333 Cr |
What is the latest Cash Flow from Investing Activities ratio of GLENMARK PHARMACEUTICALS ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-1,283 Cr |
| Mar2025 | ₹2.09 Cr |
| Mar2024 | ₹4,561 Cr |
| Mar2023 | ₹-528 Cr |
| Mar2022 | ₹-333 Cr |
How is Cash Flow from Investing Activities of GLENMARK PHARMACEUTICALS Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-1,283 Cr | Negative | |
| Mar2025 | ₹2.09 Cr | -99.95 | |
| Mar2024 | ₹4,561 Cr | Positive | |
| Mar2023 | ₹-528 Cr | Negative | |
| Mar2022 | ₹-333 Cr | - | |
Compare Cash Flow from Investing Activities of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹62,225.1 Cr | -1.8% | -7.4% | 16.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -0.2% | -4.9% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹242,904.0 Cr | 1.3% | -2.3% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹172,213.0 Cr | -1.5% | -5.8% | 29.3% | Stock Analytics | |
| CIPLA | ₹106,138.0 Cr | 0.1% | -4.2% | -14.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,304.0 Cr | 1.9% | 5.7% | 0.4% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -1.8% |
-7.4% |
16.6% |
| SENSEX | 0.9% |
-0.8% |
-10.5% |
You may also like the below Video Courses